Radiology, Vol 200, 135-141, Copyright © 1996 by Radiological Society of North America

ARTICLES

Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses

Y Anzai, WR Carroll, DJ Quint, CR Bradford, S Minoshima, GT Wolf and RL Wahl
Department of Radiology, University of Michigan Medical Center, University Hospital, Ann Arbor 48109-0028, USA.

PURPOSE: To evaluate the diagnostic accuracy of positron emission tomography (PET) with administration of 2-deoxy-2-[fluorine-18]fluoro-D- glucose (FDG) relative to that of magnetic resonance (MR) imaging and/or computed tomography (CT) in recurrent head and neck cancers. MATERIALS AND METHODS: Twelve adult patients (mean age, 63 years) with previously treated head and neck cancers and clinical suspicion of recurrence underwent FDG PET and MR imaging and/or CT. All images were blindly and independently interpreted without histopathologic findings (obtained within 1 week of imaging). The level of confidence in image interpretation was graded by using a five-point rating system (0 = definitely no recurrence to 4 = definite recurrence). RESULTS: Recurrence was confirmed in eight patients. With a rating of 4 as a positive finding, FDG PET yielded a sensitivity and specificity of 88% (seven of eight) and 100% (four of four), respectively; MR imaging and/or CT, 25% (two of eight) and 75% (three of four), respectively. Receiver-operating characteristic analysis showed significantly better diagnostic accuracy with FDG PET than with MR imaging and/or CT (area under curve = 0.96 vs 0.55, P < .03). CONCLUSION: These data indicate that PET metabolic imaging, as compared with anatomic methods, has improved diagnostic accuracy for recurrent head and neck cancer.

This article has been cited by other articles:

				M. Comoretto, L. Balestreri, E. Borsatti, M. Cimitan, G. Franchin, and M. Lise Detection and Restaging of Residual and/or Recurrent Nasopharyngeal Carcinoma after Chemotherapy and Radiation Therapy: Comparison of MR Imaging and FDG PET/CT Radiology, October 1, 2008; 249(1): 203 - 211. [Abstract] [Full Text] [PDF]

				S. Y. Kim, S.-w. Lee, S. Y. Nam, K. C. Im, J.-S. Kim, S. J. Oh, S. D. Ahn, S. S. Shin, E. K. Choi, and J. H. Kim The Feasibility of 18F-FDG PET Scans 1 Month After Completing Radiotherapy of Squamous Cell Carcinoma of the Head and Neck J. Nucl. Med., March 1, 2007; 48(3): 373 - 378. [Abstract] [Full Text] [PDF]

				T. M. Blodgett, C. C. Meltzer, and D. W. Townsend PET/CT: Form and Function Radiology, February 1, 2007; 242(2): 360 - 385. [Abstract] [Full Text] [PDF]

				M. B. Fukui, T. M. Blodgett, C. H. Snyderman, J. J. Johnson, E. N. Myers, D. W. Townsend, and C. C. Meltzer Combined PET-CT in the Head and Neck: Part 2. Diagnostic Uses and Pitfalls of Oncologic Imaging RadioGraphics, July 1, 2005; 25(4): 913 - 930. [Abstract] [Full Text] [PDF]

				B. F. Branstetter IV, T. M. Blodgett, L. A. Zimmer, C. H. Snyderman, J. T. Johnson, S. Raman, and C. C. Meltzer Head and Neck Malignancy: Is PET/CT More Accurate than PET or CT Alone? Radiology, May 1, 2005; 235(2): 580 - 586. [Abstract] [Full Text] [PDF]

				T.-C. Yen, J. T.-C. Chang, S.-H. Ng, Y.-C. Chang, S.-C. Chan, K.-J. Lin, W.-J. Lin, Y.-K. Fu, and C.-Y. Lin The Value of 18F-FDG PET in the Detection of Stage M0 Carcinoma of the Nasopharynx J. Nucl. Med., March 1, 2005; 46(3): 405 - 410. [Abstract] [Full Text] [PDF]

				V. Kapoor, M. B. Fukui, and B. M. McCook Role of 18FFDG PET/CT in the Treatment of Head and Neck Cancers: Posttherapy Evaluation and Pitfalls Am. J. Roentgenol., February 1, 2005; 184(2): 589 - 597. [Full Text] [PDF]

				N. Shu-Hang, J. C. Tung-Chieh, C. Sheng-Chieh, K. Sheung-Fat, W. Hung-Ming, L. Chun-Ta, C. Yu-Chen, W.-J. Lin, F. Ying-Kai, and Y. Tzu-Chen Clinical Usefulness of 18F-FDG PET in Nasopharyngeal Carcinoma Patients with Questionable MRI Findings for Recurrence J. Nucl. Med., October 1, 2004; 45(10): 1669 - 1676. [Abstract] [Full Text] [PDF]

				S. K. Mukherji, I. M. Schmalfuss, J. Castelijns, and A. A. Mancuso Clinical Applications of Tumor Volume Measurements for Predicting Outcome in Patients with Squamous Cell Carcinoma of the Upper Aerodigestive Tract AJNR Am. J. Neuroradiol., September 1, 2004; 25(8): 1425 - 1432. [Abstract] [Full Text] [PDF]

				H. Schoder, H. W. D. Yeung, M. Gonen, D. Kraus, and S. M. Larson Head and Neck Cancer: Clinical Usefulness and Accuracy of PET/CT Image Fusion Radiology, April 1, 2004; 231(1): 65 - 72. [Abstract] [Full Text] [PDF]

				S-H Liu, J T Chang, S-H Ng, S-C Chan, and T-C Yen False positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography finding caused by osteoradionecrosis in a nasopharyngeal carcinoma patient Br. J. Radiol., March 1, 2004; 77(915): 257 - 260. [Abstract] [Full Text] [PDF]

				S. K. Mukherji and G. T. Wolf Evaluation of Head and Neck Squamous Cell Carcinoma After Treatment AJNR Am. J. Neuroradiol., October 1, 2003; 24(9): 1743 - 1746. [Full Text] [PDF]

				T.-C. Yen, K.-K. Ng, S.-Y. Ma, H.-H. Chou, C.-S. Tsai, S. Hsueh, T.-C. Chang, J.-H. Hong, L.-C. See, W.-J. Lin, et al. Value of Dual-Phase 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Cervical Cancer J. Clin. Oncol., October 1, 2003; 21(19): 3651 - 3658. [Abstract] [Full Text] [PDF]

				G J R Cook Nuclear medicine in imaging head and neck malignancies Imaging, September 1, 2003; 15(3): 141 - 148. [Abstract] [Full Text] [PDF]

				E. Chesnay, E. Babin, J. M. Constans, D. Agostini, A. Bequignon, A. Regeasse, F. Sobrio, and S. Moreau Early Response to Chemotherapy in Hypopharyngeal Cancer: Assessment with 11C-Methionine PET, Correlation with Morphologic Response, and Clinical Outcome J. Nucl. Med., April 1, 2003; 44(4): 526 - 532. [Abstract] [Full Text] [PDF]

				S.-Y. Ryu, M.-H. Kim, S.-C. Choi, C.-W. Choi, and K.-H. Lee Detection of Early Recurrence with 18F-FDG PET in Patients with Cervical Cancer J. Nucl. Med., March 1, 2003; 44(3): 347 - 352. [Abstract] [Full Text] [PDF]

				L. Kostakoglu, H. Agress Jr, and S. J. Goldsmith Clinical Role of FDG PET in Evaluation of Cancer Patients RadioGraphics, March 1, 2003; 23(2): 315 - 340. [Abstract] [Full Text] [PDF]

				S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps A Tabulated Summary of the FDG PET Literature J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93. [Full Text] [PDF]

				V. J. Lowe, J. H. Boyd, F. R. Dunphy, H. Kim, T. Dunleavy, B. T. Collins, D. Martin, B. C. Stack Jr, C. Hollenbeak, and J. W. Fletcher Surveillance for Recurrent Head and Neck Cancer Using Positron Emission Tomography J. Clin. Oncol., February 1, 2000; 18(3): 651 - 651. [Abstract] [Full Text] [PDF]

				K. N. Ganjoo, R. J. Chan, M. Sharma, and L. H. Einhorn Positron Emission Tomography Scans in the Evaluation of Postchemotherapy Residual Masses in Patients With Seminoma J. Clin. Oncol., November 1, 1999; 17(11): 3457 - 3460. [Abstract] [Full Text] [PDF]

				V. J. Lowe, H. Kim, J. H. Boyd, J. F. Eisenbeis, F. R. Dunphy, and J. W. Fletcher Primary and Recurrent Early Stage Laryngeal Cancer: Preliminary Results of 2-[Fluorine 18]fluoro-2-deoxy-D-glucose PET Imaging Radiology, September 1, 1999; 212(3): 799 - 802. [Abstract] [Full Text]

				S. K. Mukherji, M. Gapany, D. Phillips, B. Neelon, S. O' O'Brien, W. McCartney, S. Buejenovich, J. S. Parekh, J. P. Noordzij, and M. Castillo Thallium-201 Single-Photon Emission CT versus CT for the Detection of Recurrent Squamous Cell Carcinoma of the Head and Neck AJNR Am. J. Neuroradiol., August 1, 1999; 20(7): 1215 - 1220. [Abstract] [Full Text]

				Y. Anzai, S. Minoshima, G. T. Wolf, and R. L. Wahl Head and Neck Cancer: Detection of Recurrence with Three-dimensional Principal Components Analysis at Dynamic FDG PET Radiology, July 1, 1999; 212(1): 285 - 290. [Abstract] [Full Text]